About Biocrates
Biocrates is a company based in Innsbruck (Austria) founded in 2002 was acquired by Bruker in June 2025. Biocrates has raised $7.87 million across 9 funding rounds from investors including BASF, Bruker and European Union. Biocrates has completed 1 acquisition, including Metanomics Health. Biocrates offers products and services including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ. Biocrates operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Innsbruck, Austria
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocrates Life Sciences Ag
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocrates
Biocrates offers a comprehensive portfolio of products and services, including MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ.
Kit for comprehensive metabolic profiling of lipids and small molecules.
Kit to study disease mechanisms and microbiome interactions.
High-resolution tool for targeted metabolomics data analysis.
Software for sample registration and metabolite quantification.
People of Biocrates
Unlock access to complete
Funding Insights of Biocrates
Biocrates has successfully raised a total of $7.87M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biocrates
Biocrates has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include BASF, Bruker and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology companies are managed by MIG Fonds.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investments are focused on Austrian tech and life sciences startups.
|
Locked | Locked | Locked |
Investor details for Biocrates
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocrates
Biocrates has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Metanomics Health.
Investment portfolio details for Biocrates
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Metabolomics products and services are offered for health applications.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Biocrates
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biocrates
Detailed financials for Biocrates
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocrates Comparisons
Peer comparison for Biocrates
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocrates
Biocrates operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Biocrates
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocrates
Complete news archive for Biocrates
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocrates
Biocrates was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Biocrates is headquartered in Innsbruck, Austria. It is registered at Innsbruck, Tyrol, Austria.
Biocrates is a funded company, having raised a total of $7.87M across 9 funding rounds to date.
Biocrates was founded in 2002 in Innsbruck, Austria, within the life sciences sector. Kits for targeted metabolic phenotyping are offered in two lines: research tools that quantify 188 metabolites across classes like bile salts and steroids, and diagnostic tests for analyzing 16 steroid hormones. Proprietary software is utilized to manage workflows, standardize data processing, and support project harmonization in metabolite analysis.
Biocrates's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Biocrates offers MxP Quant 500 XL, MxP Quant 500, AbsoluteIDQ p400 HR, and WebIDQ.
Biocrates has made 1 acquisition, including Metanomics Health.
Biocrates has 6 investors. Key investors include BASF, Bruker, European Union, MIG Fonds, and Global Asset Fund.